Patients with VHI health insurance are now able to access new cancer drugs that are not available to public patients, creating an official two-tier divide for “the first time”.
VHI, the biggest health insurer in the country, wrote to oncologists in recent days stating that it was extending access to innovative new drugs for patients with melanoma, breast cancer and lung cancer.
The HSE is only funding those drugs for patients with very...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team